Untitled
2021-12-09 • Jay Sharma
The global point of care (PoC) diagnostics market size is expected to reach USD 66.72 Billion by 2028 at a CAGR of 10.70%, according to a new report by Reports and Data. Growth in market revenue is attributed to rapidly growing geriatric population, increasing prevalence of target diseases worldwide, rising burden of infectious diseases such as COVID-19, and technological advancements in point of care diagnostic devices. Extensive use of point of care diagnostics for home healthcare, surging demand for rapid and accurate diagnostic results, increasing cases of COVID-19 worldwide, and rising volumes of molecular and antibody point of care diagnostic tests are the other major factors accountable for growth of the global point of care (PoC) diagnostics market.
Point of care diagnostic devices are widely used in healthcare facilities and home care settings to obtain diagnostic results of patients. These devices provide rapid feedback on various medical tests and allow healthcare professionals to achieve accurate, lab-quality diagnostic results in real-time. The key benefits of point of care diagnostics are rapid decision-making, reduced operating times, reduced post-operative care time, increased number of outpatient clinic visits, and lesser risks of antimicrobial contamination. This type of diagnostics helps doctors better diagnose and monitor a patient’s condition and their response to treatment.
Top Companies Profiled in the Report Include:
Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Becton Dickinson and Company, Abbott Laboratories, Quidel Diagnostics, Chembio Diagnostics, EKF Diagnostics, Trinity Biotech, and Fluxergy
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1507